Clinical Trial: 18F-LY3950321-01 Biodistribution and Safety Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diagnostic Agent Adverse Reaction
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label Study to Evaluate the Biodistribution and Safety of 18F-LY3950321 (18F-MNI-1256) in Healthy Subjects
Brief Summary:
18F-LY3950321 (also known as 18F-MNI-1256) is a radiolabeled positron emission tomography (PET) tracer targeting granzyme B. The overall goal of this protocol is to evaluate the safety, tolerability, and radiation dosimetry of 18F-LY3950321.
Read more